anonymous
Guest
anonymous
Guest
If I didn’t need this job I’d love to ask Albert at what point do you remove every senior leader that has contributed to our pain and suffering in the field. Your team makes poor decisions and we pay the price for it with the stress and anxiety of job loss. How about the jokers that pushed for the pain drug. The FDA shot it down with not a single advisor voting in supply of approval. There may have been one person that voted yes. The diabetes drug will be next. Pouring millions of dollars into a BID drug with significant side effects when competitors will be QD and a cleaner side-effect profile. Keep telling the analysts we are working on QD formulation. Sadly, you will be long gone before the announcement we are discontinuing our development of this product. Maybe we can relaunch inhaled insulin. That was an absolute joke. Paid Novo $1 billion for exclusive marketing rights. I think we lost $999,999,999 on that deal.